Comparison of RNF11 expression between breast, prostate, head and neck, kidney, colon and lung cancers revealed that the majority of our tumour array specimens produced clear immunostaining without any detectable background, and the morphology of the tissues was well preserved (Figure 1). Here, RNF11 is linked to lung cancer.